182 related articles for article (PubMed ID: 33777788)
1. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():634167. PubMed ID: 33777788
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():693855. PubMed ID: 34046366
[TBL] [Abstract][Full Text] [Related]
3. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
4. FAM21C Promotes Hepatocellular Carcinoma Invasion and Metastasis by Driving Actin Cytoskeleton Remodeling
Lu Y; Huang D; Wang B; Zheng B; Liu J; Song J; Zheng S
Front Oncol; 2021; 11():809195. PubMed ID: 35096613
[TBL] [Abstract][Full Text] [Related]
5. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464
[TBL] [Abstract][Full Text] [Related]
6. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
Huang D; Cao L; Zheng S
J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
[TBL] [Abstract][Full Text] [Related]
7. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
8. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
9. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
10. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
11. Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer.
Xie Z; Liang H; Wang J; Xu X; Zhu Y; Guo A; Shen X; Cao F; Chang W
Oncotarget; 2017 Dec; 8(64):108079-108092. PubMed ID: 29296225
[TBL] [Abstract][Full Text] [Related]
12. Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.
Panfil AR; Al-Saleem J; Howard CM; Shkriabai N; Kvaratskhelia M; Green PL
Front Microbiol; 2018; 9():80. PubMed ID: 29441057
[TBL] [Abstract][Full Text] [Related]
13. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of UBR5 promotes tumor growth in gallbladder cancer via PTEN/PI3K/Akt signal pathway.
Zhang Z; Zheng X; Li J; Duan J; Cui L; Yang L; Zhang L; Zhang Q; Wang X
J Cell Biochem; 2019 Jul; 120(7):11517-11524. PubMed ID: 30775814
[TBL] [Abstract][Full Text] [Related]
15. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CAPZA1 overexpression in gastric cancer.
Lee YJ; Jeong SH; Hong SC; Cho BI; Ha WS; Park ST; Choi SK; Jung EJ; Ju YT; Jeong CY; Kim JW; Lee CW; Yoo J; Ko GH
Int J Oncol; 2013 May; 42(5):1569-77. PubMed ID: 23545944
[TBL] [Abstract][Full Text] [Related]
17. UBR5 oncogene as an indicator of poor prognosis in gastric cancer.
Ding F; Zhu X; Song X; Yuan P; Ren L; Chai C; Zhou W; Li X
Exp Ther Med; 2020 Nov; 20(5):7. PubMed ID: 32934672
[TBL] [Abstract][Full Text] [Related]
18. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
20. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting
Tsugawa H; Mori H; Matsuzaki J; Sato A; Saito Y; Imoto M; Suematsu M; Suzuki H
Autophagy; 2019 Feb; 15(2):242-258. PubMed ID: 30176157
[No Abstract] [Full Text] [Related]
[Next] [New Search]